Experimental Therapies for Ebola Virus Disease: What Have We Learned?
作者信息
Hayden Frederick G, Friede Martin, Bausch Daniel G
机构信息
University of Virginia School of Medicine, Charlottesville.
World Health Organization, Geneva, Switzerland.
出版信息
J Infect Dis. 2017 Jan 15;215(2):167-170. doi: 10.1093/infdis/jiw496.
Abstract
摘要
相似文献
1
Experimental Therapies for Ebola Virus Disease: What Have We Learned?埃博拉病毒病的实验性疗法：我们学到了什么？
J Infect Dis. 2017 Jan 15;215(2):167-170. doi: 10.1093/infdis/jiw496.
2
Forgotten Ebola vaccine could help in outbreak.被遗忘的埃博拉疫苗可能有助于应对疫情。
Science. 2022 Oct 28;378(6618):340-341. doi: 10.1126/science.adf4959. Epub 2022 Oct 27.
3
Ebolavirus in West Africa, and the use of experimental therapies or vaccines.西非的埃博拉病毒以及实验性疗法或疫苗的使用。
BMC Biol. 2014 Sep 26;12:80. doi: 10.1186/s12915-014-0080-6.
4
Ebola treatments caught in limbo.埃博拉治疗陷入困境。
Nature. 2014 Jul 31;511(7511):520. doi: 10.1038/511520a.
5
Backs against the wall: novel and existing strategies used during the 2014-2015 Ebola virus outbreak.背水一战：2014 - 2015年埃博拉病毒爆发期间采用的新策略与现有策略
Clin Microbiol Rev. 2015 Jul;28(3):593-601. doi: 10.1128/CMR.00014-15.
6
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.法匹拉韦治疗埃博拉病毒病的实验性治疗（JIKI试验）：在几内亚进行的一项历史对照单臂概念验证试验。
PLoS Med. 2016 Mar 1;13(3):e1001967. doi: 10.1371/journal.pmed.1001967. eCollection 2016 Mar.
7
Humanitarian access to unapproved interventions in public health emergencies of international concern.在国际关注的突发公共卫生事件中，人道主义获取未经批准的干预措施的情况。
PLoS Med. 2015 Feb 24;12(2):e1001793. doi: 10.1371/journal.pmed.1001793. eCollection 2015 Feb.
8
DR Congo: investigational research against Ebola virus.刚果民主共和国：针对埃博拉病毒的研究性调查
Lancet. 2018 Jun 9;391(10137):2308-2309. doi: 10.1016/S0140-6736(18)31312-6. Epub 2018 Jun 7.
9
Experimental Ebola drugs face tough test in war zone.实验性埃博拉药物在战区面临严峻考验。
Nature. 2018 Sep;561(7721):14. doi: 10.1038/d41586-018-06132-7.
10
Evaluating clinical trial designs for investigational treatments of Ebola virus disease.评估埃博拉病毒病研究性治疗的临床试验设计。
PLoS Med. 2015 Apr 14;12(4):e1001815. doi: 10.1371/journal.pmed.1001815. eCollection 2015 Apr.
引用本文的文献
1
Ocular complications in Ebola virus disease survivors: the importance of continuing care in West Africa.埃博拉病毒病幸存者的眼部并发症：西非持续护理的重要性。
Expert Rev Ophthalmol. 2019;14(3):179-185. doi: 10.1080/17469899.2019.1623025. Epub 2019 Jun 4.
2
Quantification of Viral and Host Biomarkers in the Liver of Rhesus Macaques: A Longitudinal Study of Zaire Ebolavirus Strain Kikwit (EBOV/Kik).恒河猴肝脏中病毒和宿主生物标志物的定量：扎伊尔埃博拉病毒株基特（EBOV/Kik）的纵向研究。
Am J Pathol. 2020 Jul;190(7):1449-1460. doi: 10.1016/j.ajpath.2020.03.003. Epub 2020 Apr 8.
3
Calcium Ions Directly Interact with the Ebola Virus Fusion Peptide To Promote Structure-Function Changes That Enhance Infection.钙离子直接与埃博拉病毒融合肽相互作用，促进结构-功能变化，增强感染。
ACS Infect Dis. 2020 Feb 14;6(2):250-260. doi: 10.1021/acsinfecdis.9b00296. Epub 2019 Dec 10.
4
Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin.分子工程化香蕉凝集素抑制埃博拉病毒。
PLoS Negl Trop Dis. 2019 Jul 29;13(7):e0007595. doi: 10.1371/journal.pntd.0007595. eCollection 2019 Jul.
5
Current status of small molecule drug development for Ebola virus and other filoviruses.埃博拉病毒和其他丝状病毒小分子药物研发的现状。
Curr Opin Virol. 2019 Apr;35:42-56. doi: 10.1016/j.coviro.2019.03.001. Epub 2019 Apr 16.
6
Virus and host interactions critical for filoviral RNA synthesis as therapeutic targets.病毒和宿主相互作用对于丝状病毒 RNA 合成至关重要，可作为治疗靶点。
Antiviral Res. 2019 Feb;162:90-100. doi: 10.1016/j.antiviral.2018.12.006. Epub 2018 Dec 11.
7
Biothreat Agents and Emerging Infectious Disease in the Emergency Department.急诊科中的生物威胁因子与新发传染病
Emerg Med Clin North Am. 2018 Nov;36(4):823-834. doi: 10.1016/j.emc.2018.06.011. Epub 2018 Sep 6.
8
Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus.设计和开发针对埃博拉病毒的疫苗、药物和疗法的进展。
Front Immunol. 2018 Aug 10;9:1803. doi: 10.3389/fimmu.2018.01803. eCollection 2018.
9
Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses.抑制嘧啶生物合成通过核苷酸池耗竭和先天免疫反应的激活来损害埃博拉病毒复制。
Antiviral Res. 2018 Oct;158:288-302. doi: 10.1016/j.antiviral.2018.08.012. Epub 2018 Aug 23.
10
What treating Ebola means for pandemic influenza.治疗埃博拉对大流行性流感意味着什么。
J Public Health Policy. 2018 Aug;39(3):268-282. doi: 10.1057/s41271-018-0138-8.
本文引用的文献
1
First Newborn Baby to Receive Experimental Therapies Survives Ebola Virus Disease.首例接受实验性疗法的新生儿从埃博拉病毒病中康复。
J Infect Dis. 2017 Jan 15;215(2):171-174. doi: 10.1093/infdis/jiw493.
2
A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection.ZMapp治疗埃博拉病毒感染的随机对照试验。
N Engl J Med. 2016 Oct 13;375(15):1448-1456. doi: 10.1056/NEJMoa1604330.
3
Experimental Treatment of Ebola Virus Disease with Brincidofovir.用布林西多福韦对埃博拉病毒病进行实验性治疗。
PLoS One. 2016 Sep 9;11(9):e0162199. doi: 10.1371/journal.pone.0162199. eCollection 2016.
4
Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 Days.几内亚埃博拉病毒病的卷土重来与一名精液中病毒持续存在超过500天的幸存者有关。
Clin Infect Dis. 2016 Nov 15;63(10):1353-1356. doi: 10.1093/cid/ciw601. Epub 2016 Sep 1.
5
The Ebola clinical trials: a precedent for research ethics in disasters.埃博拉临床试验：灾难研究伦理学的先例。
J Med Ethics. 2018 Jan;44(1):3-8. doi: 10.1136/medethics-2016-103474. Epub 2016 Aug 29.
6
West Africa 2013: Re-examining Ebola.西非 2013 年：重新审视埃博拉。
Microbiol Spectr. 2016 Jun;4(3). doi: 10.1128/microbiolspec.EI10-0022-2016.
7
Late Ebola virus relapse causing meningoencephalitis: a case report.晚期埃博拉病毒复发致脑膜脑炎：一例报告
Lancet. 2016 Jul 30;388(10043):498-503. doi: 10.1016/S0140-6736(16)30386-5. Epub 2016 May 18.
8
Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial.TKM-130803用于埃博拉病毒病的实验性治疗：一项单臂2期临床试验。
PLoS Med. 2016 Apr 19;13(4):e1001997. doi: 10.1371/journal.pmed.1001997. eCollection 2016 Apr.
9
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys.小分子GS-5734对恒河猴体内埃博拉病毒的治疗效果。
Nature. 2016 Mar 17;531(7594):381-5. doi: 10.1038/nature17180. Epub 2016 Mar 2.
10
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.法匹拉韦治疗埃博拉病毒病的实验性治疗（JIKI试验）：在几内亚进行的一项历史对照单臂概念验证试验。
PLoS Med. 2016 Mar 1;13(3):e1001967. doi: 10.1371/journal.pmed.1001967. eCollection 2016 Mar.
Zotero 插件